ASK Biosimilars: oncology biosimilars
Launched in December 2021, the ASK Biosimilars programme offers multi-format education resources on the use of biosimilars to our community of oncologists and hospital pharmacists.
Developed by PCM Scientific, the ASK Biosimilars programme provides free educational resources to enhance learning on the use of biosimilars. This includes 10 learning chapters, a library of 30 abstracts, local guideline summary documents, an archive of expert-led webinars, and a downloadable handbook.
To reach our community of oncologists and hospital pharmacists across Western Europe, Canada and Japan, the ASK platform has been translated into English, French, German, Italian, Japanese and Spanish, and is promoted through our media brands Hospital Healthcare Europe and Hospital Pharmacy Europe.
To date, the programme has generated over 11,970 unique engagements and over 5,340 website users. This success has resulted in the platform being expanded to include an abstract library and case studies showcasing real-world evidence of the use of biosimilars. Due to launch this month, the programme will not only now reach our audience of oncologists and hospital pharmacists in Europe, but also Canada, the US and Australia, as well as payors.